Rentschler Biopharma
Laupheim, Germany
Program data pending ClinicalTrials.gov matching
· Last scored 2026-10-29
77.8
Signal Score
✓ FDA Inspections (2)
○ Clinical Trials
○ SEC Filings
✓ Press (4)
✓ EMA GMP (2)
○ MHRA GMP
✓ HC GMP (8)
Quick Facts: Rentschler Biopharma
- Signal Score
- 77.8/100 (as of 2026-10-29)
- Quality Compliance
- 99.2/100
- Headquarters
- Laupheim, Germany
- Website
- https://rentschler-biopharma.com
- Modalities
- Monoclonal Antibody, Recombinant Protein
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Rentschler Biopharma
Pure-play CDMO.
Signal Score & Pillar Breakdown
Quality Compliance
99.2
FDA Inspections2 on record
Warning Letters0
Last InspectionVoluntary Action Indicated (VAI) (2025-01-17)
EMA GMP Certificates2 on record
Most Recent HC OutcomeCompliant · 2023-05-05
HC Attribution8 company-level
Source: Health Canada Drug and Health Product Inspections Database. Ratings shown in Health Canada's own vocabulary; not equivalent to FDA classifications. Company-level records are attributed by the regulator's published establishment name, not by a verified site identifier. Contains information licensed under the Open Government Licence – Canada.
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesMonoclonal Antibody, Recombinant Protein
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
58.0
1 manufacturing site: Laupheim, DE
Modalities: Monoclonal Antibody, Recombinant Protein
Capacity assessment: 58.0/100
Sites: Laupheim, DE
Source: company profiles (manufacturing sites, modality breadth)
1 manufacturing site
Press Signals4 articles (not scored)
1 manufacturing site: Laupheim, DE
Modalities: Monoclonal Antibody, Recombinant Protein
Capacity assessment: 58.0/100
Rentschler Biopharma FDA Inspection History
2025-01
2023-05
NAI
VAI
OAI
| Date | Site | Type | 483 citations posted | Classification |
|---|---|---|---|---|
| 2025-01-17 |
Rentschler Biopharma Inc.
Milford, Massachusetts
Facility-linked
|
Drug Quality Assurance | Not posted | Voluntary Action Indicated (VAI) |
| 2023-05-05 |
Rentschler Biopharma SE
Laupheim
Company-level
|
Drug Quality Assurance | Not posted | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Nov 21, 2026
Rentschler Biopharma EMA GMP Compliance 2 certificates
2026-02
2023-05
Compliant
Non-Compliant
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| DE_BW_01_GMP_2026_0092 | Rentschler Biopharma SE | Germany | 2026-02-05 | COMPLIANT |
| DE_BW_01_GMP_2025_0209 | Rentschler Biopharma SE | Germany | 2023-05-05 | COMPLIANT |
Source: EMA EudraGMDP · Retrieved Nov 21, 2026
Japan-accredited overseas site (PMDA)
sterile, biologics · 2 sites
- Laupheim, Germany · Rentschler Biopharma SE — sterile, biologics · valid to May 30, 2028
- Milford, United States · Rentschler Biopharma Inc. — biologics · valid to Oct 5, 2031
Previously accredited (cancelled) · 1
- Laupheim, Germany · Rentschler Biopharma SE — sterile, biologics · cancelled Oct 1, 2017
No longer on PMDA's current list. Shown for history only; not used in search tags.
PMDA accreditation of a foreign manufacturing site is recognition within Japan's regulatory system, not an inspection outcome. PMDA's list covers only manufacturing sites outside Japan, so a company's plants in Japan are not on it. Source: PMDA, list of accredited/registered foreign manufacturers (as of Oct 16, 2026), Public Data License 1.0 (terms)
Hiring Activity 38 open roles Beta
From public job postings on Rentschler Biopharma's careers board, as of Nov 20, 2026. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
38
open roles
21
in manufacturing, quality, PD/MSAT, engineering or regulatory (55%)
Trend from Nov 25, 2026
Tracking started Oct 26, 2026. 30-day change shows after 30 days, 90-day after Jan 24, 2027.
Since Nov 19, 2026: 2 new postings, 2 taken down.
What this may mean
- 6 of the 13 openings at Milford MA United States are in quality (QA/QC). That fits added testing or batch-release work, but it can also be normal turnover.
By function
By site
Laupheim Germany
profile site
6 mfg/ops · 3 QA/QC · 2 eng. · 14 other 25
6 mfg/ops · 3 QA/QC · 2 eng. · 14 other 25
Milford MA United States
profile site
3 mfg/ops · 6 QA/QC · 1 PD/MSAT · 3 other 13
3 mfg/ops · 6 QA/QC · 1 PD/MSAT · 3 other 13
Modality words in job titles
Biologics (cell culture, USP/DSP)1
Notable roles
Director, Quality Control Technical Services
Senior operations / quality role · Milford MA United States
Director, Quality Control, Analytics
Senior operations / quality role · Milford MA United States
Senior Director Quality Assurance, QP
Senior operations / quality role · Laupheim Germany
Latest postings
Recruiter
Other (finance, HR, IT, other) · Laupheim Germany
Quality Control Data Reviewer
Quality (QA / QC) · Milford MA United States
Werkstudent, Support Splkche
Other (finance, HR, IT, other) · Laupheim Germany
Pharmazeutischer Operator, DSP, 1 Jahresvertrag
Manufacturing & operations · Laupheim Germany
Production Planner Scheduler
Manufacturing & operations · Milford MA United States
MES Implementation Project Manager
Commercial, BD & client projects · Milford MA United States
Pharmazeutischer Operator, Produktion Support, 1 Jahresvertrag
Manufacturing & operations · Laupheim Germany
Director, Quality Control Technical Services
Quality (QA / QC) · Milford MA United States
Werkstudent, Technik und Standortentwicklung
Other (finance, HR, IT, other) · Laupheim Germany
Manufacturing Associate II, Buffer Media Services, 3 6 Month Contract
Manufacturing & operations · Milford MA United States
Sachbearbeiter, QA Systeme, 2 Jahresvertrag
Quality (QA / QC) · Laupheim Germany
Process Manager, DSP
Other (finance, HR, IT, other) · Laupheim Germany
Coverage: counted from Rentschler Biopharma's own careers board.
Function groups come mainly from job titles (about 84% match a hand check), and modality words from titles only, so both are approximate.
Source:
rentschler.wd3.myworkdayjobs.com
· Checked Nov 20, 2026 · Tracking since Oct 26, 2026
Company Signals 4 articles
Company announcements, not verified evidence. They do not change any score.
Together We Build: Rentschler Biopharma celebrates Milford site progress and growth since U.S. expansion - Manufacturing Digital Magazine
Together We Build: Rentschler Biopharma celebrates Milford site progress and growth since U.S. expansion Manufacturing Digital Magazine
Rentschler Biopharma Advances Milford Site Expansion - Contract Pharma
Rentschler Biopharma Advances Milford Site Expansion Contract Pharma
Together We Build: Rentschler Biopharma celebrates Milford site progress and growth since U.S. expansion - GlobeNewswire
Together We Build: Rentschler Biopharma celebrates Milford site progress and growth since U.S. expansion GlobeNewswire
Together We Build: Rentschler Biopharma celebrates Milford site progress and growth since U.S. expansion - GlobeNewswire
Together We Build: Rentschler Biopharma celebrates Milford site progress and growth since U.S. expansion GlobeNewswire
Frequently Asked Questions About Rentschler Biopharma
How many FDA inspections does Rentschler Biopharma have on record?
CDMO Signal tracks 2 FDA inspections for Rentschler Biopharma, sourced from the FDA inspection database. See the full inspection history above.
Has Rentschler Biopharma received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Rentschler Biopharma.
Does Rentschler Biopharma hold EMA or MHRA GMP certificates?
CDMO Signal tracks 2 EMA GMP certificates for Rentschler Biopharma.
What is Rentschler Biopharma's CDMO Signal Score?
Rentschler Biopharma has a Signal Score of 78/100, based on quality, operations, financial stability, and capacity data.
Evaluating Rentschler Biopharma for a manufacturing program?
Use the free AI matchmaker to compare Rentschler Biopharma against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
KBI Biopharma
Durham, NC · Boulder, CO
Signal Score: 84.1
Monoclonal Antibody, Recombinant Protein, AAV (analytical only), Plasmid DNA
AGC Biologics
Longmont, CO · Milan, IT · Copenhagen, DK · Chiba, JP
Signal Score: 79.9
CAR-T, Cell Therapy, AAV, Lentiviral, ADC, Monoclonal Antibody, Recombinant Protein, Microbial Fermentation
Catalent
Tampa, FL
Signal Score: 76.1
Monoclonal Antibody, Recombinant Protein, ADC, AAV, mRNA, Plasmid DNA, Fill-Finish
Lonza
Basel, Switzerland
Signal Score: 72.8
AAV, Lentiviral, Cell Therapy, mRNA, ADC, Monoclonal Antibody, Recombinant Protein, Microbial Fermentation, Small Molecule API, High-Potency APIs, Oral Solid Dose
Samsung Biologics
Incheon, South Korea, Rockville, Maryland, USA
Signal Score: 61.5
Monoclonal Antibody, Recombinant Protein, ADC, mRNA, Bispecific Antibody, Antibody Conjugate
Compare Rentschler Biopharma with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.